Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan-Reference-Cited by-同舟云学术

Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan

Published:2020-07-28 Issue:9 Volume:111 Page:3386-3394
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Tsumura Ryo¹^ORCID,Koga Yoshikatsu²^ORCID,Hamada Akinobu³,Kuwata Takeshi⁴,Sasaki Hiroki⁵^ORCID,Doi Toshihiko⁶,Aikawa Katsuji⁷,Ohashi Akihiro⁸,Katano Ikumi⁹,Ikarashi Yoshinori¹⁰,Ito Mamoru⁹,Ochiai Atsushi¹¹^ORCID

Affiliation:

1. Division of Developmental Therapeutics Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

2. Department of Strategic Programs Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

3. Division of Molecular Pharmacology and Pharmacokinetics National Cancer Center Research Institute Tokyo Japan

4. Department of Pathology and Clinical Laboratories National Cancer Center Hospital East Kashiwa Japan

5. Department of Translational Oncology Fundamental Innovative Oncology Core Center National Cancer Center Research Institute Tokyo Japan

6. Department of Experimental Therapeutics National Cancer Center Hospital East Kashiwa Japan

7. Seeds Development Support Section Translational Research Management Division National Cancer Center Hospital East Kashiwa Japan

8. Division of Translational Genomics Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

9. Central Institute for Experimental Animals Kawasaki Japan

10. Office of New Drug V Pharmaceuticals and Medical Devices Agency Tokyo Japan

11. Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14564

Reference21 articles.

1. High drug attrition rates—where are we going wrong?

2. Hallmarks of Cancer: The Next Generation

3. Tumor endothelial cells accelerate tumor metastasis

4. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment

5. CAFs and TAMs: maestros of the tumour microenvironment

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies;Pharmaceuticals;2024-08-09

2. Post-Implantation Inflammatory Responses to Xenogeneic Tissue-Engineered Cartilage Implanted in Rabbit Trachea: The Role of Cultured Chondrocytes in the Modification of Inflammation;International Journal of Molecular Sciences;2023-11-26

3. Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin;Biomedicine & Pharmacotherapy;2023-11

4. Organoids: approaches and utility in cancer research;Chinese Medical Journal;2023-06-26

5. Establishment of humanized mice and its application progress in cancer immunotherapy;Immunotherapy;2023-06